<DOC>
	<DOCNO>NCT00945555</DOCNO>
	<brief_summary>The purpose study define classify antibacterial agent use Turkey patient febrile neutropenia .</brief_summary>
	<brief_title>Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options</brief_title>
	<detailed_description />
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<criteria>Patients 18 year old . Patients undergone allogeneic/autologous peripheral stem cell transplantation follow induction consolidation treatment due acute hematological malignancy . Patients neutrophil count 500 cell per cubic millimeter ( cells/mm^3 ) 1000 cells/mm^3 expectancy rapidly decrease 500 cells/mm^3 . Patients body temperature equal ( ≥ ) 38.3 degree Celsius ( 101 degree Fahrenheit ) single oral measurement detect ≥38.0 degree Celsius least hour thus start antibacterial treatment include trial . Patients pregnant consider pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Antibacterials</keyword>
	<keyword>Classification antibacterial agent</keyword>
	<keyword>Febrile neutropenia</keyword>
	<keyword>Turkey</keyword>
</DOC>